Medicare Enrolled
Dr. Maen Hussein, M.D.
Hematology · Lady Lake, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hussein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hussein? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hussein
Dr. Maen Hussein is a hematology in Lady Lake, FL, with 20 years in practice. Based on federal Medicare data, Dr. Hussein performed 342,147 Medicare services across 8,728 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hussein received a total of $179,385 from 110 pharmaceutical and/or device companies across 1340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hussein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 6% volume in FL$ $179,385 industry payments
Medicare Practice Summary
Medicare Utilization ↗342,147
Medicare services
Top 6% in FL for hematology
8,728
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~17,107 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 75,480 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 57,300 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 26,200 | $43 | $137 |
| Paclitaxel chemotherapy injection | 25,364 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 24,570 | $1 | $5 |
| Iron sucrose injection (Venofer) | 20,400 | $0 | $5 |
| Daratumumab injection (Darzalex) | 15,840 | $38 | $110 |
| Oxaliplatin chemotherapy injection | 15,700 | $0 | $12 |
| Denosumab injection (Prolia/Xgeva) | 12,660 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 9,720 | $6 | $23 |
| Dexamethasone injection (steroid) | 7,963 | $0 | $3 |
| Immune globulin infusion (Gammagard) | 7,756 | $36 | $108 |
| Injection, docetaxel, 1 mg | 6,558 | $1 | $7 |
| Complete blood count (CBC) with differential | 5,605 | $8 | $29 |
| Blood draw (venipuncture) | 5,364 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,160 | $1 | $28 |
| Office visit, established patient (20-29 min) | 2,707 | $65 | $239 |
| Iron infusion (Monoferric) | 2,600 | $17 | $57 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,464 | $23 | $185 |
| Anti-nausea injection (ondansetron/Zofran) | 1,776 | $0 | $9 |
| Office visit, established patient (30-39 min) | 1,346 | $96 | $339 |
| Drug injection, under skin or into muscle | 1,285 | $10 | $69 |
| Injection of additional new drug or substance into vein | 1,211 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 1,201 | $97 | $378 |
| Injection, carboplatin, 50 mg | 865 | $2 | $41 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 610 | $3 | $205 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 563 | $46 | $189 |
| Injection, leucovorin calcium, per 50 mg | 545 | $3 | $12 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 533 | $1 | $6 |
| Injection, diphenhydramine hcl, up to 50 mg | 415 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 373 | $21 | $79 |
| Administration of additional new drug or substance into vein, 1 hour or less | 356 | $49 | $178 |
| Injection, fluorouracil, 500 mg | 353 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 341 | $22 | $84 |
| Injection, zoledronic acid, 1 mg | 321 | $7 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 239 | $15 | $56 |
| Infusion into a vein for hydration, each additional hour | 222 | $10 | $42 |
| Injection of drug or substance into vein | 163 | $27 | $156 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 136 | $24 | $89 |
| New patient office visit (45-59 min) | 136 | $128 | $453 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 136 | $17 | $59 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 134 | $54 | $206 |
| Initial hospital admission, moderate complexity | 120 | $101 | $377 |
| Automated urinalysis | 114 | $2 | $8 |
| Infusion, normal saline solution , 1000 cc | 109 | $2 | $7 |
| Prothrombin time test (blood clotting) | 103 | $4 | $15 |
| Administration of additional new drug or substance into vein using push technique | 82 | $42 | $170 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 79 | $132 | $562 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 78 | $3 | $11 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 72 | $1 | $7 |
| Hospital follow-up visit, low complexity | 69 | $39 | $109 |
| Infusion into a vein for hydration, 31-60 minutes | 60 | $24 | $156 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 59 | $176 | $587 |
| CT guidance for radiation therapy | 57 | $57 | $300 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 57 | $270 | $1,100 |
| Red blood count, automated test | 53 | $4 | $10 |
| Hospital follow-up visit, moderate complexity | 50 | $63 | $197 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 40 | $41 | $144 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 37 | $15 | $56 |
| New patient office visit (30-44 min) | 37 | $75 | $298 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 35 | $113 | $637 |
| Office visit, established patient (10-19 min) | 32 | $39 | $147 |
| Initial hospital admission, high complexity | 28 | $132 | $556 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 28 | $4 | $15 |
| Drawing of blood for a medical problem | 26 | $70 | $277 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 19 | $130 | $467 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $41 | $115 |
| Transitional care management services for problem of high complexity | 14 | $214 | $722 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
25.6% high complexity
69.6% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$179,385
Total received (2018-2024)
Avg $25,626/year across 7 years
Top 1% in FL for hematology
110
Companies
1,340
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90,324 (50.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$70,109 (39.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,019 (10.0%)
Other
Charitable contributions, space rental, and other categories
$933 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$27,444
2023$33,509
2022$13,932
2021$15,191
2020$17,756
2019$25,473
2018$46,081
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Incyte Corporation
$25,854
E.R. Squibb & Sons, L.L.C.
$21,226
Ipsen Biopharmaceuticals, Inc
$14,277
AstraZeneca Pharmaceuticals LP
$12,978
PFIZER INC.
$12,194
F. Hoffmann-La Roche AG
$9,037
Boehringer Ingelheim International GmbH
$8,149
Bayer HealthCare Pharmaceuticals Inc.
$5,828
Janssen Biotech, Inc.
$4,648
Lilly USA, LLC
$4,012
MorphoSys, US Inc.
$3,841
GENZYME CORPORATION
$3,736
Daiichi Sankyo Inc.
$3,528
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,349
Karyopharm Therapeutics Inc.
$3,126
PharmaEssentia USA Corporation
$2,807
Novartis Pharmaceuticals Corporation
$2,583
Janssen Scientific Affairs, LLC
$2,532
AbbVie Inc.
$2,429
Athenex Pharmaceutical Division, LLC
$2,420
ABBVIE INC.
$1,970
Adaptive Biotechnologies Corporation
$1,962
Azurity Pharmaceuticals, Inc.
$1,875
AVEO Pharmaceuticals, Inc.
$1,865
Stemline Therapeutics Inc.
$1,730
Genentech USA, Inc.
$1,674
Pharmacyclics LLC, An AbbVie Company
$1,636
Celgene Corporation
$1,276
JAZZ PHARMACEUTICALS INC.
$1,244
Heron Therapeutics, Inc.
$1,207
Genentech, Inc.
$1,200
CTI BioPharma Corp.
$1,160
Amgen Inc.
$848
Eli Lilly and Company
$800
Merck Sharp & Dohme LLC
$632
Seagen Inc.
$603
Gilead Sciences, Inc.
$582
Merck Sharp & Dohme Corporation
$552
BeiGene USA, Inc.
$531
AMAG Pharmaceuticals, Inc.
$520
Boehringer Ingelheim Pharma GmbH & Co.KG
$511
Eisai Inc.
$406
Kite Pharma, Inc.
$397
GlaxoSmithKline, LLC.
$356
Astellas Pharma US Inc
$335
Octapharma USA, Inc.
$332
Blueprint Medicines Corporation
$315
EISAI INC.
$314
Foundation Medicine, Inc.
$211
EMD Serono, Inc.
$206
Takeda Pharmaceuticals U.S.A., Inc.
$192
ADC Therapeutics America, Inc.
$173
Regeneron Healthcare Solutions, Inc.
$170
Alexion Pharmaceuticals, Inc.
$159
Rigel Pharmaceuticals, Inc.
$149
Seattle Genetics, Inc.
$143
Clovis Oncology, Inc.
$136
SOBI, INC
$135
Agios Pharmaceuticals, Inc.
$134
Pharmacyclics LLC, an AbbVie Company
$120
Intuitive Surgical, Inc.
$115
Genmab U.S., Inc.
$113
Bayer Healthcare Pharmaceuticals Inc.
$109
NOVARTIS PHARMACEUTICALS CORPORATION
$100
ARRAY BIOPHARMA INC
$88
G1 Therapeutics, Inc.
$87
Taiho Oncology, Inc.
$85
TESARO, Inc.
$81
Pharmacosmos Therapeutics Inc.
$77
Exelixis Inc.
$75
Global Blood Therapeutics, Inc.
$71
Apellis Pharmaceuticals, Inc.
$69
Aurobindo Pharma USA, Inc.
$66
Lexicon Pharmaceuticals, Inc.
$65
TerSera Therapeutics LLC
$62
Kyowa Kirin, Inc.
$57
Dova Pharmaceuticals
$56
Array BioPharma Inc.
$51
Verastem, Inc.
$43
Dendreon Pharmaceuticals LLC
$38
Vanda Pharmaceuticals Inc.
$37
CSL Behring
$34
Jazz Pharmaceuticals Inc.
$31
Mirati Therapeutics, Inc.
$30
Secura Bio, Inc.
$29
ImmunoGen, Inc.
$28
Puma Biotechnology, Inc.
$26
PUMA BIOTECHNOLOGY, INC.
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$25
Telix Pharmaceuticals
$23
SERVIER PHARMACEUTICALS LLC
$20
AbbVie, Inc.
$19
TG Therapeutics, Inc.
$19
Partner Therapeutics, Inc.
$18
NanoString Technologies, Inc.
$18
Sun Pharmaceutical Industries Inc.
$17
Tempus AI, Inc
$17
R-Pharm US LLC
$16
Deciphera Pharmaceuticals Inc.
$16
Spectrum Pharmaceuticals Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$15
Novocure Inc.
$13
Acrotech Biopharma LLC
$12
GE HEALTHCARE
$12
Sirtex Medical Inc
$12
Teva Pharmaceuticals USA, Inc.
$12
TOLMAR Pharmaceuticals, Inc.
$11
SECURA BIO, INC.
$9
Janssen Pharmaceuticals, Inc
$6
Veracyte, Inc.
$1
Top 3 companies account for 34.2% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Afstyla · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BENLYSTA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CHANTIX · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Cinvanti · Copiktra · Cresemba · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · EVENITY · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAVRETO · GAZYVA · GILOTRIF · Gazyva · Halaven · Herceptin · Hetlioz · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · Inrebic · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Oncology · Onivyde · Oral Paclitaxel · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · Quzyttir · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TAXOTERE · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · VIVIMUSTA · VYXEOS · Vanflyta · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology in FL.
Equivalent to $52 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
9
Per 100K population
2.3
County median income
$69,956
Nearest hospital
VILLAGES REGIONAL HOSPITAL, THE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hussein is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hussein experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Hussein performed 75,480 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hussein receive payments from pharmaceutical companies?
Yes. Dr. Hussein received a total of $179,385 from 110 companies across 1,340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hussein's costs compare to other hematologys in Lady Lake?
Dr. Hussein's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hussein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Lady Lake
Browse hematologys in Lady Lake ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Ipsen Biopharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ipsen Biopharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology